Literature DB >> 19701895

Induction of peripheral CD4+ T-cell tolerance and CD8+ T-cell cross-tolerance by dendritic cells.

Manfred B Lutz1, Christian Kurts.   

Abstract

DC can present and cross-present self-antigens to autoreactive CD4(+) and CD8(+) T cells, respectively, and incapacitate them by inducing anergy, deletion or converting them into Treg. In this review, we summarize the recent progress in immune tolerance research, which has been achieved by employing antigen- and TCR-transgenic mice. We cover the numerous discoveries that have furthered our knowledge of the DC subsets and maturation pathways involved in tolerance; the signals, such as CD70, TGF-beta, B7-H1/PD-L1, which dictate the decision between immunity and tolerance; and the in vivo role of DC in the maintenance of CD4(+) T-cell tolerance and CD8(+) T-cell cross-tolerance.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19701895     DOI: 10.1002/eji.200939548

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  33 in total

1.  Immune modulation of co-transplantation mesenchymal stem cells with islet on T and dendritic cells.

Authors:  F R Li; X G Wang; C Y Deng; H Qi; L L Ren; H X Zhou
Journal:  Clin Exp Immunol       Date:  2010-05-07       Impact factor: 4.330

2.  Reproductive immunology: a focus on the role of female sex hormones and other gender-related factors.

Authors:  Elena Peeva
Journal:  Clin Rev Allergy Immunol       Date:  2011-02       Impact factor: 8.667

Review 3.  Cross-priming in health and disease.

Authors:  Christian Kurts; Bruce W S Robinson; Percy A Knolle
Journal:  Nat Rev Immunol       Date:  2010-06       Impact factor: 53.106

Review 4.  Multifunctional dendritic cell-targeting polymeric microparticles: engineering new vaccines for type 1 diabetes.

Authors:  Benjamin G Keselowsky; Chang Qing Xia; Michael Clare-Salzler
Journal:  Hum Vaccin       Date:  2011-01-01

5.  Alternative cross-priming through CCL17-CCR4-mediated attraction of CTLs toward NKT cell-licensed DCs.

Authors:  Verena Semmling; Veronika Lukacs-Kornek; Christoph A Thaiss; Thomas Quast; Katharina Hochheiser; Ulf Panzer; Jamie Rossjohn; Patrick Perlmutter; Jia Cao; Dale I Godfrey; Paul B Savage; Percy A Knolle; Waldemar Kolanus; Irmgard Förster; Christian Kurts
Journal:  Nat Immunol       Date:  2010-02-28       Impact factor: 25.606

Review 6.  Cross-presentation by dendritic cells.

Authors:  Olivier P Joffre; Elodie Segura; Ariel Savina; Sebastian Amigorena
Journal:  Nat Rev Immunol       Date:  2012-07-13       Impact factor: 53.106

Review 7.  Mesenchymal stem cells help pancreatic islet transplantation to control type 1 diabetes.

Authors:  Marina Figliuzzi; Barbara Bonandrini; Sara Silvani; Andrea Remuzzi
Journal:  World J Stem Cells       Date:  2014-04-26       Impact factor: 5.326

8.  Alloantigen specific deletion of primary human T cells by Fas ligand (CD95L)-transduced monocyte-derived killer-dendritic cells.

Authors:  Christian Schütz; Sabine Hoves; Dagmar Halbritter; Huang-Ge Zhang; John D Mountz; Martin Fleck
Journal:  Immunology       Date:  2011-02-22       Impact factor: 7.397

9.  Intravenous transfer of apoptotic cell-treated dendritic cells leads to immune tolerance by blocking Th17 cell activity.

Authors:  Fang Zhou; Elisabetta Lauretti; Antonio di Meco; Bogoljub Ciric; Patricia Gonnella; Guang-Xian Zhang; Abdolmohamad Rostami
Journal:  Immunobiology       Date:  2013-03-01       Impact factor: 3.144

10.  Delivery of Exogenous Antigens to Induce Cytotoxic CD8+ T Lymphocyte Responses.

Authors:  Julia Kim; Vandana Gambhir; Attiya Alatery; Sameh Basta
Journal:  J Biomed Biotechnol       Date:  2010-05-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.